Clinical implications of a molecular genetic classification of monogenic β-cell diabetes
The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Monogenic diabetes resulting from mutations that primarily reduce beta-cell function accounts for 1-2% of diabetes cases, although it is often misdiagnosed as either type 1 or type 2 diabetes. Knowledge of the genetic etiology of diabetes enables more-appropriate treatment, better prediction of disease progression, screening of family members and genetic counseling. We propose that the old clinical classifications of maturity-onset diabetes of the young and neonatal diabetes are obsolete and that specific genetic etiologies should be sought in four broad clinical situations because of their specific treatment implications. Firstly, diabetes diagnosed before 6 months of age frequently results from mutation of genes that encode Kir6.2 (ATP-sensitive inward rectifier potassium channel) or sulfonylurea receptor 1 subunits of an ATP-sensitive potassium channel, and improved glycemic control can be achieved by treatment with high-dose sulfonylureas rather than insulin. Secondly, patients with stable, mild fasting hyperglycemia detected particularly when they are young could have a glucokinase mutation and might not require specific treatment. Thirdly, individuals with familial, young-onset diabetes that does not fit with either type 1 or type 2 diabetes might have mutations in the transcription factors HNF-1alpha (hepatocyte nuclear factor 1-alpha) or HNF-4alpha, and can be treated with low-dose sulfonylureas. Finally, extrapancreatic features, such as renal disease (caused by muta…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, an exception is the mutational analyses established for classification of diabetes in the neonate (381-384) as well as in young individuals with a dominant family history of diabetes, often referred to as maturityonset diabetes of the young (MODY) (384,385) (Table 8).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [383]
In the citing paper
“Infants with neonatal diabetes due to a mutation in the KCNJ11 (potassium inwardly-rectifying channel, subfamily J, member 11; also known as KIR6.2) gene may be treated with sulfonylurea rather than with insulin (258,259).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [258]
In the citing paper
“Genetic markers are currently of limited clinical value in evaluating and managing patients with diabetes; however, mutational analysis is rapidly emerging for classifying diabetes in the neonate (258-260) and in young patients with a dominant family history of diabetes, often referred to as “maturityonset diabetes of the young” (MODY) (261).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [258]
Citations
Cites
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Goto, Y.-I., Nonaka, I., & Horai, S. (1990) · Nature · doi:10.1038/348651a0 · Cited by 2,070
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137
Self-citationSwitching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Self-citationChatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C., & Bowcock, A. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11679 · Cited by 940
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924 · cited 1×
“Currently, insulin remains the most common treatment during pregnancy for this patient group, but further studies are required to validate the safety and efficacy of sulfonylureas such as glibenclamide (also known as glyburide) that have least permeability through the placenta and have been used in gestational diabetes”
BackgroundEarly-onset type-ll diabetes mellitus (MODY4) linked to IPF1
Staffers, D. A., Ferrer, J., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng1097-138 · Cited by 882
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Froguel, P., Zouali, H., Vionnet, N., Velho, G., Vaxillaire, M., Sun, F., Lesage, S., Stoffel, M., Takeda, J., Passa, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281005 · Cited by 735 · cited 1×
“Most of those without diabetes have impaired fasting glucose levels”
BackgroundGudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J. T., Thorleifsson, G., Manolescu, A., Rafnar, T., Gudbjartsson, D., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2062 · Cited by 723 · cited 1×
“Common variants in the HNF1B gene are associated with an increased risk for prostate cancer but protect against type 2 diabetes”
BackgroundWildin, R. S., Smyk-Pearson, S., & Filipovich, A. H. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.537 · Cited by 711
Activating Mutations in the ABCC8 Gene in Neonatal Diabetes Mellitus
Babenko, A. P., Polak, M., Cavé, H., Busiah, K., Czernichow, P., Scharfmann, R., Bryan, J., Aguilar-Bryan, L., Vaxillaire, M., & Froguel, P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055068 · Cited by 655
Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus
Malecki, M. T., Jhala, U. S., Antonellis, A., Fields, L., Doria, A., Orban, T., Saad, M., Warram, J. H., Montminy, M., & Krolewski, A. S. (1999) · Nature Genetics · doi:10.1038/15500 · Cited by 619
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607 · cited 1×
“Management The importance of diagnosing patients who have HNF1A diabetes is that this type of diabetes is very sensitive to sulfonylurea therapy”
BackgroundSelf-citationMutations in the glucokinase gene of the fetus result in reduced birth weight
Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., & Ellard, S. (1998) · Nature Genetics · doi:10.1038/953 · Cited by 594
Self-citationInsulin gene mutations as a cause of permanent neonatal diabetes
Støy, J., Edghill, E. L., Flanagan, S. E., Ye, H., Paz, V. P., Pluzhnikov, A., Below, J. E., Hayes, M. G., Cox, N. J., Lipkind, G. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707291104 · Cited by 564
Self-citationMutations in PTF1A cause pancreatic and cerebellar agenesis
Sellick, G. S., Barker, K. T., Stolte-Dijkstra, I., Fleischmann, C., J Coleman, R., Garrett, C., Gloyn, A. L., Edghill, E. L., Hattersley, A. T., Wellauer, P. K., et al. (2004) · Nature Genetics · doi:10.1038/ng1475 · Cited by 454
Self-citationMaassen, J. A., ‘t Hart, L. M., van Essen, E., Heine, R. J., Nijpels, G., Jahangir Tafrechi, R. S., Raap, A. K., Janssen, G. M. C., & Lemkes, H. H. P. J. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s103 · Cited by 439 · cited 1×
“Diabetes in MIDD usually presents insidiously in a similar way to type 2 diabetes, but approximately 20% of patients have an acute presentation that resembles that of type 1 diabetes, with ketoacidosis occurring in 8%”
BackgroundPearson, E. R., Boj, S. F., Steele, A. M., Barrett, T., Stals, K., Shield, J. P., Ellard, S., Ferrer, J., & Hattersley, A. T. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040118 · Cited by 427 · cited 1×
“Increased birth weight (by ∼800 g) and macrosomia are common features of HNF4A mutation carriers, and transient neonatal hypoglycemia may precede the diabetes”
BackgroundSelf-citationNeonatal Diabetes Mellitus Due to Complete Glucokinase Deficiency
Njølstad, P. R., Søvik, O., Cuesta-Muñoz, A., Bjørkhaug, L., Massa, O., Barbetti, F., Undlien, D. E., Shiota, C., Magnuson, M. A., Molven, A., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105243442104 · Cited by 424
Activating Mutations in Kir6.2 and Neonatal Diabetes
Hattersley, A. T., & Ashcroft, F. M. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2503 · Cited by 414
Self-citationSenée, V., Chelala, C., Duchatelet, S., Feng, D., Blanc, H., Cossec, J.-C., Charon, C., Nicolino, M., Boileau, P., Cavener, D. R., et al. (2006) · Nature Genetics · doi:10.1038/ng1802 · Cited by 376
Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction
Ræder, H., Johansson, S., Holm, P. I., Haldorsen, I. S., Mas, E., Sbarra, V., Nermoen, I., Eide, S. Å., Grevle, L., Bjørkhaug, L., et al. (2006) · Nature Genetics · doi:10.1038/ng1708 · Cited by 376
Lindner, T. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.11.2001 · Cited by 367 · cited 1×
“Female genital-tract malformations, gout and hyperuricemia can also occur ( Figure 3A )”
BackgroundFlanagan, S. E., Patch, A.-M., Mackay, D. J. G., Edghill, E. L., Gloyn, A. L., Robinson, D., Shield, J. P. H., Temple, K., Ellard, S., & Hattersley, A. T. (2007) · Diabetes · doi:10.2337/db07-0043 · Cited by 357 · cited 1×
“The diabetes resolves in approximately half of all patients with neonatal diabetes, and the majority of cases of TNDM (∼70%) are linked to abnormalities in the chromosome 6q24 region”
BackgroundSelf-citationMild Familial Diabetes with Dominant Inheritance
(1974) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067391 · Cited by 354
Mutations in hepatocyte nuclear factor-1β and their related phenotypes
Edghill, E. L., Bingham, C., Ellard, S., & Hattersley, A. T. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.032854 · Cited by 344 · cited 1×
“Diabetes diagnosed before 6 months of age Diabetes diagnosed before 6 months of age is likely to be one of the monogenic forms of neonatal diabetes and not autoimmune type 1 diabetes”
BackgroundSelf-citationPermanent Neonatal Diabetes due to Mutations in KCNJ11 Encoding Kir6.2
Sagen, J. V., Ræder, H., Hathout, E., Shehadeh, N., Gudmundsson, K., Bævre, H., Abuelo, D., Phornphutkul, C., Molnes, J., Bell, G. I., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2713 · Cited by 333
Self-citationMaternally Inherited Diabetes and Deafness: A Multicenter Study
Guillausseau, P.-J., Massin, P., Dubois-LaForgue, D., Timsit, J., Virally, M., Gin, H., Bertin, E., Blickle, J.-F., Bouhanick, B., Cahen, J., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-9_part_1-200105010-00008 · Cited by 314
Murphy, R., Turnbull, D. M., Walker, M., & Hattersley, A. T. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02359.x · Cited by 291
Self-citationThe genetic abnormality in the beta cell determines the response to an oral glucose load
Stride, A., Vaxillaire, M., Tuomi, T., Barbetti, F., Njølstad, P. R., Hansen, T., Costa, A., Conget, I., Pedersen, O., Søvik, O., et al. (2002) · Diabetologia · doi:10.1007/s00125-001-0770-9 · Cited by 277 · cited 1×
“Patients with mutated GCK produce adequate insulin responses, and most have a small increment in plasma glucose (”
BackgroundSelf-citationBellanné-Chantelot, C., Clauin, S., Chauveau, D., Collin, P., Daumont, M., Douillard, C., Dubois-Laforgue, D., Dusselier, L., Gautier, J.-F., Jadoul, M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3126 · Cited by 275 · cited 1×
“A family history of renal disease (or diabetes) is not essential to prompt a screen for this disorder, as spontaneous mutations and deletions of this gene are common (one-third to two-thirds of cases)”
BackgroundVelho, G., Blanché, H., Vaxillaire, M., Bellanné-Chantelot, C., Pardini, V. C., Timsit, J., Passa, P., Deschamps, I., Robert, J.-J., Weber, I. T., et al. (1997) · Diabetologia · doi:10.1007/s001250050666 · Cited by 266
Renal Phenotypes Related to Hepatocyte Nuclear Factor-1β (TCF2) Mutations in a Pediatric Cohort
Ulinski, T., Lescure, S., Beaufils, S., Guigonis, V., Decramer, S., Morin, D., Clauin, S., Desche[Combining Circumflex Accent]nes, G., Bouissou, F. C., Bensman, A., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101040 · Cited by 265
Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes.
Temple, I. K., Gardner, R. J., Mackay, D. J., Barber, J. C., Robinson, D. O., & Shield, J. P. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1359 · Cited by 263
Baud, O., Goulet, O., Canioni, D., Le Deist, F., Radford, I., Rieu, D., Dupuis-Girod, S., Cerf-Bensussan, N., Cavazzana-Calvo, M., Brousse, N., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442304 · Cited by 263
Byrne, M. M., Sturis, J., Menzel, S., Yamagata, K., Fajans, S. S., Dronsfield, M. J., Bain, S. C., Hattersley, A. T., Velho, G., Froguel, P., et al. (1996) · Diabetes · doi:10.2337/diab.45.11.1503 · Cited by 259
Self-citationTransient neonatal diabetes, a disorder of imprinting: Figure 1
Temple, I. K., & Shield, J. P. H. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.12.872 · Cited by 250 · cited 1×
“Therapy Treatment during the neonatal phase is with insulin; however, on relapse treatment may include dietary modification, oral hypoglycemic agents and/or insulin”
BackgroundPearson, E. R., Pruhova, S., Tack, C. J., Johansen, A., Castleden, H. A. J., Lumb, P. J., Wierzbicki, A. S., Clark, P. M., Lebl, J., Pedersen, O., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1738-y · Cited by 232 · cited 1×
“In patients with young-onset diabetes, lack of obesity, absence of acanthosis nigricans or polycystic ovarian syndrome, and elevated or normal HDL-cholesterol and reduced or normal triglyceride level”
BackgroundSelf-citationFlanagan, S. E., Edghill, E. L., Gloyn, A. L., Ellard, S., & Hattersley, A. T. (2006) · Diabetologia · doi:10.1007/s00125-006-0246-z · Cited by 227
Self-citationEllard, S., Flanagan, S. E., Girard, C. A., Patch, A.-M., Harries, L. W., Parrish, A., Edghill, E. L., Mackay, D. J. G., Proks, P., Shimomura, K., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519174 · Cited by 215
Self-citationEllard, S., Beards, F., Allen, L. I. S., Shepherd, M., Ballantyne, E., Harvey, R., & Hattersley, A. T. (2000) · Diabetologia · doi:10.1007/s001250050038 · Cited by 209
Self-citationRenal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1
Bingham, C. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh348 · Cited by 193 · cited 1×
“Female genital-tract malformations, gout and hyperuricemia can also occur ( Figure 3A )”
BackgroundSenée, V., Vattem, K. M., Delépine, M., Rainbow, L. A., Haton, C., Lecoq, A., Shaw, N. J., Robert, J.-J., Rooman, R., Diatloff-Zito, C., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1876 · Cited by 193
Chronic diabetic complications in patients with MODY3 diabetes
Isomaa, B., Henricsson, M., Lehto, M., Forsblom, C., Karanko, S., Sarelin, L., Häggblom, M., & Groop, L. (1998) · Diabetologia · doi:10.1007/s001250050931 · Cited by 192 · cited 1×
“The frequency of microvascular complications in patients with HNF1A diabetes is similar to that in patients with type 1 and type 2 diabetes, and is related to poor glycemic control”
ResultEllard, S., & Colclough, K. (2006) · Human Mutation · doi:10.1002/humu.20357 · Cited by 191
Self-citationPermanent Neonatal Diabetes Caused by Glucokinase Deficiency
Njølstad, P. R., Sagen, J. V., Bjørkhaug, L., Odili, S., Shehadeh, N., Bakry, D., Sarici, S. U., Alpay, F., Molnes, J., Molven, A., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2854 · Cited by 189
Vaxillaire, M., Populaire, C., Busiah, K., Cavé, H., Gloyn, A. L., Hattersley, A. T., Czernichow, P., Froguel, P., & Polak, M. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2719 · Cited by 186
Self-citationAgenesis of Human Pancreas due to Decreased Half-Life of Insulin Promoter Factor 1
Schwitzgebel, V. M., Mamin, A., Brun, T., Ritz-Laser, B., Zaiko, M., Maret, A., Jornayvaz, F. R., Theintz, G. E., Michielin, O., Melloul, D., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030046 · Cited by 175
Edghill, E. L., Bingham, C., Slingerland, A. S., Minton, J. A. L., Noordam, C., Ellard, S., & Hattersley, A. T. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01999.x · Cited by 174 · cited 1×
“Birth weight is reduced by around 800 g as a result of reduced insulin secretion in utero”
BackgroundSelf-citationPAX4 Mutations in Thais with Maturity Onset Diabetes of the Young
Plengvidhya, N., Kooptiwut, S., Songtawee, N., Doi, A., Furuta, H., Nishi, M., Nanjo, K., Tantibhedhyangkul, W., Boonyasrisawat, W., Yenchitsomanus, P.-T., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1927 · Cited by 172 · cited 1×
“Two different mutations in the transcription factor gene PAX4 (paired box 4 gene) have been identified in Thai families with MODY”
BackgroundDifferent genes, different diabetes: lessons from maturity-onset diabetes of the young
Stride, A., & Hattersley, A. T. (2002) · Annals of Medicine · doi:10.1080/713782136 · Cited by 164
Self-citationPermanent diabetes mellitus in the first year of life
and the Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology, Iafusco, D., Stazi, M. A., Cotichini, R., Cotellessa, M., Martinucci, M., Mazzella, M., Cherubini, V., Barbetti, F., Martinetti, M., et al. (2002) · Diabetologia · doi:10.1007/s00125-002-0837-2 · Cited by 159 · cited 1×
“Diabetes diagnosed before 6 months of age Diabetes diagnosed before 6 months of age is likely to be one of the monogenic forms of neonatal diabetes and not autoimmune type 1 diabetes”
BackgroundContrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1α and -1β Mutations
Pearson, E. R., Badman, M. K., Lockwood, C. R., CLARK, P. M. S., Ellard, S., Bingham, C., & Hattersley, A. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1102 · Cited by 147 · cited 1×
“Half of all HNF1B mutation carriers have early-onset diabetes that presents in a similar fashion to HNF1A diabetes, but HNF1B mutation carriers are more insulin resistant”
BackgroundSelf-citationYorifuji, T., Kurokawa, K., Mamada, M., Imai, T., Kawai, M., Nishi, Y., Shishido, S., Hasegawa, Y., & Nakahata, T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031828 · Cited by 136 · cited 1×
“Penetrance There is wide variation in phenotypes even within a single pedigree, such that different combinations and severities of organ involvement are manifest among affected individuals who have identical mutations”
BackgroundStride, A., Ellard, S., Clark, P. M. S., Shakespeare, L., Salzmann, M. B., Shepherd, M. H., & Hattersley, A. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1751 · Cited by 132 · cited 1×
“Glycosuria is a key feature of HNF1A mutation carriers before they develop diabetes”
BackgroundSelf-citationSlingerland, A. S., Nuboer, R., Hadders‐Algra, M., Hattersley, A. T., & Bruining, G. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0407-0 · Cited by 129
Self-citationHarries, L. W., Ellard, S., Stride, A., Morgan, N. G., & Hattersley, A. T. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl147 · Cited by 127
Self-citationStride, A., Shepherd, M. H., Frayling, T. M., Bulman, M. P., Ellard, S., & Hattersley, A. T. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2287 · Cited by 122
Self-citationInfluence of maternal and fetal glucokinase mutations in gestational diabetes
Spyer, G., Hattersley, A. T., Sykes, J. E., Sturley, R., & MacLeod, K. M. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.113127 · Cited by 116 · cited 1×
“Pregnancy is the one exception in which hypoglycemic medication might be appropriate, but insulin is required only in cases in which there is excess fetal growth”
BackgroundSelf-citationMODY in Iceland is associated with mutations in HNF -1? and a novel mutation in NeuroD1
Kristinsson, S. Y., Talseth‐Palmer, B. A., Steingrı́msson, E., Þórsson, Á. V., Helgason, T., Hreidarsson, Á. B., Thorolfsdottir, E. T., & Arngrı́msson, R. (2001) · Diabetologia · doi:10.1007/s001250100016 · Cited by 110 · cited 1×
“Other etiologies Mutations in the transcription factor genes PDX1 and NEUROD1 are extremely rare”
BackgroundRæder, H., Haldorsen, I. S., Ersland, L., Grüner, R., Taxt, T., Sövik, O., Molven, A., & Njølstad, P. R. (2007) · Diabetes · doi:10.2337/db06-0859 · Cited by 108 · cited 1×
“At least seven discrete genetic etiologies of diabete”
BackgroundPatch, A., Flanagan, S. E., Boustred, C. R., Hattersley, A. T., & Ellard, S. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00772.x · Cited by 101
Self-citationMutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism.
Lehto, M. J., Bitzén, P. ‐., Isomaa, B., Wipemo, C., Wessman, Y., Forsblom, C. M., Tuomi, T., Taskinen, M., & Groop, L. (1999) · Diabetes · doi:10.2337/diabetes.48.2.423 · Cited by 100 · cited 1×
“In patients with young-onset diabetes, lack of obesity, absence of acanthosis nigricans or polycystic ovarian syndrome, and elevated or normal HDL-cholesterol and reduced or normal triglyceride level”
BackgroundGloyn, A. L., Cummings, E. A., Edghill, E. L., Harries, L. W., Scott, R. R., Costa, T., Temple, I. K., Hattersley, A. T., & Ellard, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0568 · Cited by 90 · cited 1×
“Unaffected parents of a child with a de novo mutation, however, should be counseled that the recurrence risk of a second child being affected is not negligible because germline mosaicism (in which mutations may be present in the gonads but not detectable in blood) has been reported in several families”
BackgroundSelf-citationMasia, R., Koster, J. C., Tumini, S., Chiarelli, F., Colombo, C., Nichols, C. G., & Barbetti, F. (2007) · Diabetes · doi:10.2337/db06-1275 · Cited by 90
Slingerland, A. S., & Hattersley, A. T. (2005) · Annals of Medicine · doi:10.1080/07853890510007287 · Cited by 87
Self-citationNew ABCC8 Mutations in Relapsing Neonatal Diabetes and Clinical Features
Vaxillaire, M., Dechaume, A., Busiah, K., Cavé, H., Pereira, S., Scharfmann, R., de Nanclares, G. P., Castaño, L. A., Froguel, P., Polak, M., et al. (2007) · Diabetes · doi:10.2337/db06-1540 · Cited by 85 · cited 1×
“Mutations in KCNJ11 or ABCC8 can also cause TNDM”
BackgroundKobayashi, T., Nakanishi, K., Nakase, H., Kajio, H., Okubo, M., Murase, T., & Kosáka, K. (1997) · Diabetes · doi:10.2337/diacare.46.10.1567 · Cited by 83 · cited 1×
“This dysfunction causes abnormal β-cell function, reduction in β-cell mas”
BackgroundEthel Codner, D., Flanagan, S. E., Ellard, S., García, H., & Hattersley, A. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.758 · Cited by 80
Self-citationTaha, D. R., Barbar, M., Kanaan, H. D., & Balfe, J. W. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20267 · Cited by 75
Guillausseau, P.-J., Dubois‐Laforgue, D., Massin, P., Laloi-Michelin, M., Bellanné‐Chantelot, C., Gin, H., Bertin, É., Blicklé, J., Bauduceau, B., Bouhanick, B., et al. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70105-2 · Cited by 72 · cited 1×
“Diabetes in MIDD usually presents insidiously in a similar way to type 2 diabetes, but approximately 20% of patients have an acute presentation that resembles that of type 1 diabetes, with ketoacidosis occurring in 8%”
BackgroundMitochondrial diabetes: Pathophysiology, clinical presentation, and genetic analysis
Maassen, J. A. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10346 · Cited by 71 · cited 1×
“3243A>G mutation is age dependent, but is estimated to be more than 85% by the age of 70 years”
BackgroundVelho, G., Hattersley, A. T., & Froguel, P. (2000) · Diabetologia · doi:10.1007/s001250051490 · Cited by 71 · cited 1×
“If the fetus does not inherit the GCK mutation it will respond to maternal hyperglycemia by excess insulin production and, therefore, excess growth; however, if the fetus does inherit the GCK mutation it will produce normal amounts of insulin and grow normally”
BackgroundSelf-citationIyer, S., Korada, M., Rainbow, L., Kirk, J. M. W., Brown, R., Shaw, N., & Barrett, T. G. (2004) · Acta Paediatrica · doi:10.1111/j.1651-2227.2004.tb02748.x · Cited by 68
Shimomura, K., Girard, C. A. J., Proks, P., Nazim, J., Lippiat, J. D., Cerutti, F., Lorini, R., Ellard, S., Hattersley, A. T., Barbetti, F., et al. (2006) · Diabetes · doi:10.2337/db05-1640 · Cited by 67
Self-citationOrigin of de Novo KCNJ11 Mutations and Risk of Neonatal Diabetes for Subsequent Siblings
Edghill, E. L., Gloyn, A. L., Goriely, A., Harries, L. W., Flanagan, S. E., Rankin, J., Hattersley, A. T., & Ellard, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2817 · Cited by 61 · cited 1×
“Unaffected parents of a child with a de novo mutation, however, should be counseled that the recurrence risk of a second child being affected is not negligible because germline mosaicism (in which mutations may be present in the gonads but not detectable in blood) has been reported in several families”
BackgroundSelf-citationHeteroplasmic ratio of the A3243G mitochondrial DNA mutation in single pancreatic beta cells
Lynn, S., Borthwick, G. M., Charnley, R., Walker, M., & Turnbull, D. M. (2003) · Diabetologia · doi:10.1007/s00125-002-1018-z · Cited by 58 · cited 1×
“This dysfunction causes abnormal β-cell function, reduction in β-cell mas”
BackgroundShepherd, M. H., Sparkes, A. C., & Hattersley, A. T. (2001) · Practical Diabetes · doi:10.1002/pdi.108 · Cited by 58 · cited 1×
“Penetrance HNF1A mutations have a high penetrance, with 63% of carriers developing diabetes by 25 years of age, 79% by 35 years and 96% by 55 years”
BackgroundSelf-citationPermanent neonatal diabetes in an Asian infant
Porter, J. R., Shaw, N. J., Barrett, T. G., Hattersley, A. T., Ellard, S., & Gloyn, A. L. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.09.008 · Cited by 57
Self-citationWalker, K. Z., O’Dea, K., Nicholson, G. C., & Muir, J. G. (1995) · Diabetes Care · doi:10.2337/diacare.18.3.401 · Cited by 53
Yoo, H., Shin, Y., Seo, E., & Kim, G.-H. (2002) · European Journal of Pediatrics · doi:10.1007/s00431-002-0931-y · Cited by 53
Liu, L., Furuta, H., Minami, A., Zheng, T., Jia, W., Nanjo, K., & Xiang, K. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9463-0 · Cited by 48 · cited 1×
“Other etiologies Mutations in the transcription factor genes PDX1 and NEUROD1 are extremely rare”
BackgroundSchnyder, S., Ellard, S., & Hattersley, A. T. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.11030 · Cited by 35
Self-citationEvolution of the glucokinase glucose sensor paradigm for pancreatic beta cells
Matschinsky, F. M., & Randle, P. J. (1993) · Diabetologia · doi:10.1007/bf00401072 · Cited by 22
Genetic testing for maturity onset diabetes of the young in childhood hyperglycaemia
Matyka, K. A., Beards, F., Appleton, M., Ellard, S., Hattersley, A. T., & Dunger, D. B. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.78.6.552 · Cited by 18 · cited 1×
“Making a genetic diagnosis of glucokinase hyperglycemia is, therefore, worthwhile”
BackgroundSelf-citationWalker, M., Taylor, R., Stewart, M., Bindoff, L., Shearing, P., Anyaoku, V., Jackson, M., Humphriss, D., Johnston, D., Alberti, K., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.11.1507 · Cited by 16
Liljestr�m, B., Aktan–Collan, K., Isomaa, B., Sarelin, L., Uutela, A. K., Groop, L., K��ri�inen, H., & Tuomilehto, J. (2005) · Diabetologia · doi:10.1007/s00125-004-1629-7 · Cited by 11 · cited 1×
“The main advantages of knowing this genetic information include reduction in uncertainty over the risk of diabetes and increased efficiency in monitoring for early signs of diabetes”
Background[Mutations in the mitochondrial gene in patients with NIDDM].
Kadowaki, T. (1994) · PubMed · Cited by 2
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s · cited 1×
“Since the classification of diabetes was revised in 1998 to reflect etiology”
Background
Research works printed but not linked: 1
- Pearson E et al. (2003) HDL-cholesterol: differentiating between HNF-1α MODY and type 2 diabetes [abstract]. Diabet Med 20 (Suppl 2): S1–S33
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
“2) gene may be treated with sulfonylurea rather than with insulin (258,259).”
Diabetes mellitus: The epidemic of the century
Kharroubi, A. T. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.850 · Cited by 1,229
The genetic architecture of type 2 diabetes
Fuchsberger, C., Flannick, J., Teslovich, T. M., Mahajan, A., Agarwala, V., Gaulton, K. J., Ma, C., Fontanillas, P., Moutsianas, L., McCarthy, D. J., et al. (2016) · Nature · doi:10.1038/nature18642 · Cited by 1,051
Self-citationRare Variants of IFIH1 , a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes
Nejentsev, S., Walker, N., Riches, D., Egholm, M., & Todd, J. A. (2009) · Science · doi:10.1126/science.1167728 · Cited by 958
Genomics, type 2 diabetes, and obesity
McCarthy, M. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906948 · Cited by 938
Metadata
- Authors
- Murphy, R., Ellard, S., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- Corresponding author
- Hattersley, Andrew T
- Venue
- Nature Clinical Practice Endocrinology & Metabolism
- Published
- 2008-02-26
- Volume
- 4
- Issue
- 4
- Pages
- 200-213
- ISSN
- 1745-8366 (ISSN-L)
- 1745-8374
- OpenAlex
- W1996549380
- Semantic Scholar
- ca1487d43edc4a5abbe40904a2e6414a4534638e
- Cited by
- 502
- References
- 91
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 10 · 2023: 18 · 2022: 17 · 2021: 33 · 2020: 23 · 2019: 21 · 2018: 34 · 2017: 32 · 2016: 33 · 2015: 33 · 2014: 36 · 2013: 29 · 2012: 42
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- monogenic diabetes, maturity-onset diabetes of the young, neonatal diabetes, molecular genetic classification, Kir6.2, SUR1, sulfonylurea therapy, glucokinase mutations, HNF1A, HNF4α, HNF1B, genetic counseling, insulin therapy
- MeSH terms
- Kcnj11 Channel, Diabetes Mellitus, Diagnosis, Differential, Female, Glucokinase, Humans, Infant, Newborn, Male, Mutation, Receptors, Drug, Potassium Channels, ATP-Binding Cassette Transporters, Potassium Channels, Inwardly Rectifying, Insulin-Secreting Cells, Hepatocyte Nuclear Factor 1-alpha, Hepatocyte Nuclear Factor 4, Sulfonylurea Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.